Search

everythinglearnresearchcommunity

for

Search:↓

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and hormonal therapy.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

The study found genetic differences related to hair development that may explain hair loss in a patient with Trichorhinophalangeal syndrome type I.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

A man with KID syndrome developed a rare cancer in a long-term skin infection.

Eosinophilia-myalgia syndrome, linked to contaminated L-tryptophan supplements, caused severe symptoms and some deaths, with long-term effects in survivors.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.